Pharmacogenetics in IBS: update and impact of GWAS studies in drug targets and metabolism

References

• Camilleri M, Chedid V. Leading article: actionable biomarkers: the key to resolving disorders of gastrointestinal function. Gut. 2020;69(10):1730–1737. doi: 10.1136/gutjnl-2019-320325
   PubMed Web of Science ®Google Scholar
• Camilleri M, BouSaba J. Potential value of biomarker-based approaches for evaluation and management of costly functional gastrointestinal diseases. Clin Gastroenterol Hepatol. 2023;21(10):2462–2472. doi: 10.1016/j.cgh.2023.04.030
   PubMed Web of Science ®Google Scholar
• Collins FS, Varmus H. A new initiative on precision medicine. N Engl J Med. 2015;372(9):793–795.
   PubMed Web of Science ®Google Scholar
• Eugene AR. Optimizing drug selection in psychopharmacology based on 40 significant CYP2C19- and CYP2D6-biased adverse drug reactions of selective serotonin reuptake inhibitors. Peer J. 2019 Oct 9;7:e7860. eCollection 2019. doi: 10.7717/peerj.7860
   PubMed Web of Science ®Google Scholar
• Keefer L, Ballou SK, Drossman DA, et al. A rome working team report on brain-gut behavior therapies for disorders of gut-brain interaction. Gastroenterology. 2022;162(1):300–315. doi: 10.1053/j.gastro.2021.09.015
   PubMed Web of Science ®Google Scholar
• Moshiree B, Drossman D, Shaukat A. AGA clinical practice update on evaluation and management of belching, abdominal bloating, and distention: expert review. Gastroenterology. 2023;165(3):791–800.e3. doi: 10.1053/j.gastro.2023.04.039
   PubMed Web of Science ®Google Scholar
• Camilleri M. Implications of pharmacogenomics to the management of IBS. Clin Gastroenterol Hepatol. 2019;17(4):584–594. doi: 10.1016/j.cgh.2018.04.052
   PubMed Web of Science ®Google Scholar
• Bielinski SJ, Olson JE, Pathak J, et al. Preemptive genotyping for personalized medicine: design of the right drug, right dose, right time—using genomic data to individualize treatment protocol. Mayo Clin Proc. 2014;89(1):25–33. doi: 10.1016/j.mayocp.2013.10.021
   PubMed Web of Science ®Google Scholar
• Camilleri M. The role of pharmacogenetics in nonmalignant gastrointestinal diseases. Nat Rev Gastroenterol Hepatol. 2012;9(3):173–184. doi: 10.1038/nrgastro.2012.2
   PubMed Web of Science ®Google Scholar
• Pentikis HS, Connolly M, Trapnell CB, et al. The effect of multiple-dose, oral rifaximin on the pharmacokinetics of intravenous and oral midazolam in healthy volunteers. Pharmacotherapy. 2007;27(10):1361–1369. doi: 10.1592/phco.27.10.1361
   PubMed Web of Science ®Google Scholar
• Wang Z, Lin YS, Zheng XE, et al. An inducible cytochrome P450 3A4-dependent vitamin D catabolic pathway. Mol Pharmacol. 2012;81(4):498–509. doi: 10.1124/mol.111.076356
   PubMed Web of Science ®Google Scholar
• Hicks JK, Bishop JR, Sangkuhl K, et al. Clinical pharmacogenetics implementation consortium (CPIC) guideline for CYP2D6 and CYP2C19 genotypes and dosing of selective serotonin reuptake inhibitors. Clin Pharmacol Ther. 2015;98(2):127–134. doi: 10.1002/cpt.147
   PubMed Web of Science ®Google Scholar
• Camilleri M, Katzka DA. Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Genetic epidemiology and pharmacogenetics in irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol. 2012;302(10):G1075–84.
   PubMed Web of Science ®Google Scholar
• Camilleri M. Genetics of human gastrointestinal sensation. Neurogastroenterol Motil. 2013;25(6):458–466. doi: 10.1111/nmo.12132
   PubMed Web of Science ®Google Scholar
• Rao A, Wong B, Camilleri M, et al. Chenodeoxycholate in females with irritable bowel syndrome-constipation: a pharmacodynamic and pharmacogenetic analysis. Gastroenterology. 2010;139(5):1549. doi: 10.1053/j.gastro.2010.07.052
   PubMed Web of Science ®Google Scholar
• Wong BS, Camilleri M, Carlson PJ, et al. Pharmacogenetics of the effects of colesevelam on colonic transit in irritable bowel syndrome with diarrhea. Dig Dis Sci. 2012;57(5):1222–1226. doi: 10.1007/s10620-012-2035-5
   PubMed Web of Science ®Google Scholar
• Wong BS, Camilleri M, Eckert D, et al. Randomized pharmacodynamic and pharmacogenetic trial of dronabinol effects on colon transit in irritable bowel syndrome-diarrhea. Neurogastroenterol Motil. 2012;24(4):358–65.e169. doi: 10.1111/j.1365-2982.2011.01874.x
   PubMed Web of Science ®Google Scholar
• Lesch KP, Bengel D, Heils A, et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science. 1996;274(5292):1527–1531. doi: 10.1126/science.274.5292.1527
   PubMed Web of Science ®Google Scholar
• Fukudo S, Kanazawa M, Mizuno T, et al. Impact of serotonin transporter gene polymorphism on brain activation by colorectal distention. Neuroimage. 2009;47(3):946–951. doi: 10.1016/j.neuroimage.2009.04.083
   PubMed Web of Science ®Google Scholar
• Camilleri M, Atanasova E, Carlson PJ, et al. Serotonin-transporter polymorphism pharmacogenetics in diarrhea-predominant irritable bowel syndrome. Gastroenterology. 2002;123(2):425–432. doi: 10.1053/gast.2002.34780
   PubMed Web of Science ®Google Scholar
• Li Y, Nie Y, Xie J, et al. The association of serotonin transporter genetic polymorphisms and irritable bowel syndrome and its influence on tegaserod treatment in Chinese patients. Dig Dis Sci. 2007;52(11):2942–2949. doi: 10.1007/s10620-006-9679-y
   PubMed Web of Science ®Google Scholar
• Zhang ZF, Duan ZJ, Wang LX, et al. The serotonin transporter gene polymorphism (5-HTTLPR) and irritable bowel syndrome: a meta-analysis of 25 studies. BMC Gastroenterol. 2014;14(1):23. doi: 10.1186/1471-230X-14-23
   PubMedGoogle Scholar
• Colucci R, Gambaccini D, Ghisu N, et al. Influence of the serotonin transporter 5HTTLPR polymorphism on symptom severity in irritable bowel syndrome. PLOS ONE. 2013;8(2):e54831. doi: 10.1371/journal.pone.0054831
   PubMed Web of Science ®Google Scholar
• Jun S, Kohen R, Cain KC, et al. Associations of tryptophan hydroxylase gene polymorphisms with irritable bowel syndrome. Neurogastroenterol Motil. 2011;23(3):233–e116. doi: 10.1111/j.1365-2982.2010.01623.x
   PubMed Web of Science ®Google Scholar
• Shiotani A, Kusunoki H, Ishii M, et al. Pilot study of biomarkers for predicting effectiveness of ramosetron in diarrhea-predominant irritable bowel syndrome: expression of S100A10 and polymorphisms of TPH1. Neurogastroenterol Motil. 2015;27(1):82–91. doi: 10.1111/nmo.12473
   PubMed Web of Science ®Google Scholar
• Kapeller J, Houghton LA, Monnikes H, et al. First evidence for an association of a functional variant in the microRNA-510 target site of the serotonin receptor-type 3E gene with diarrhea predominant irritable bowel syndrome. Hum Mol Genet. 2008;17(19):2967–2977. doi: 10.1093/hmg/ddn195
   PubMed Web of Science ®Google Scholar
• Kilpatrick LA, Labus JS, Coveleskie K, et al. The HTR3A polymorphism c. -42C > T is associated with amygdala responsiveness in patients with irritable bowel syndrome. Gastroenterology. 2011;140:1943–1951. doi: 10.1053/j.gastro.2011.03.011
   PubMed Web of Science ®Google Scholar
• Hammer C, Kapeller J, Endele M, et al. Functional variants of the serotonin receptor type 3A and B gene are associated with eating disorders. Pharmacogenet Genomics. 2009;19(10):790–799. doi: 10.1097/FPC.0b013e32833132b3
   PubMed Web of Science ®Google Scholar
• Yamada K, Hattori E, Iwayama Y, et al. Distinguishable haplotype blocks in the HTR3A and HTR3B region in the Japanese reveal evidence of association of HTR3B with female major depression. Biol Psychiatry. 2006;60(2):192–201. doi: 10.1016/j.biopsych.2005.11.008
   PubMed Web of Science ®Google Scholar
• Berens S, Dong Y, Fritz N, et al. Serotonin type 3 receptor subunit gene polymorphisms associated with psychosomatic symptoms in irritable bowel syndrome: a multicenter retrospective study. World J Gastroenterol. 2022;28(21):2334–2349. doi: 10.3748/wjg.v28.i21.2334
   PubMed Web of Science ®Google Scholar
• Kapeller J, Moller D, Lasitschka F, et al. Serotonin receptor diversity in the human colon: expression of serotonin type 3 receptor subunits 5-HT3C, 5-HT3D, and 5-HT3E. J Comp Neurol. 2011;519(3):420–432. doi: 10.1002/cne.22525
   PubMed Web of Science ®Google Scholar
• Gu QY, Zhang J, Feng YC, et al. Association of genetic polymorphisms in HTR3A and HTR3E with diarrhea predominant irritable bowel syndrome. Int J Clin Exp Med. 2015;8(3):4581–4585.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Huang Y, Bo P. Association between diarrhea-predominant irritable bowel syndrome and HTR3A, HTR3E gene polymorphism in Yangzhou,Jiangsu province, China. Zhonghua Liu Xing Bing Xue Za Zhi. 2013;34(7):721–724.
   PubMedGoogle Scholar
• Zhang Y, Li Y, Hao Z, et al. Association of the serotonin receptor 3E Gene as a functional variant in the MicroRNA-510 target site with diarrhea predominant irritable bowel syndrome in Chinese women. J Neurogastroenterol Motil. 2016;22(2):272–281. doi: 10.5056/jnm15138
   PubMed Web of Science ®Google Scholar
• Camilleri M, Carlson P, BouSaba J, et al. Comparison of biochemical, microbial, and mucosal mRNA expression in bile acid diarrhea and irritable bowel syndrome-diarrhea. Gut. 2023;72(1):54–65. doi: 10.1136/gutjnl-2022-327471
   PubMed Web of Science ®Google Scholar
• Wong B, Camilleri M, Carlson P, et al. A Klothoβ variant mediates protein stability and associates with colon transit in irritable bowel syndrome with diarrhea. Gastroenterology. 2011;140(7):1934–1942. doi: 10.1053/j.gastro.2011.02.063
   PubMed Web of Science ®Google Scholar
• Camilleri M, Shin A, Busciglio I, et al. Genetic variation in GPBAR1 predisposes to quantitative changes in colonic transit and bile acid excretion. Am J Physiol Gastrointest Liver Physiol. 2014;307(5):G508–16. doi: 10.1152/ajpgi.00178.2014
   PubMed Web of Science ®Google Scholar
• Camilleri M, Kolar GJ, Vazquez-Roque MI, et al. Cannabinoid receptor 1 gene and irritable bowel syndrome: phenotype and quantitative traits. Am J Physiol Gastrointest Liver Physiol. 2013;304(5):G553–60. doi: 10.1152/ajpgi.00376.2012
   PubMed Web of Science ®Google Scholar
• Camilleri M, Carlson P, McKinzie S, et al. Genetic variation in endocannabinoid metabolism, gastrointestinal motility, and sensation. Am J Physiol Gastrointest Liver Physiol. 2008;294(1):G13–9. doi: 10.1152/ajpgi.00371.2007
   PubMed Web of Science ®Google Scholar
• Celli J, Rappold G, Niesler B. The human serotonin type 3 receptor gene (HTR3A-E) allelic variant database. Human Mutation. 2017;38(2):137–147. doi: 10.1002/humu.23136
   PubMed Web of Science ®Google Scholar
• Kalantar JS, GR L 3rd, Zinsmeister AR, et al. Familial aggregation of irritable bowel syndrome: a prospective study. Gut. 2003;52(12):1703–1707. doi: 10.1136/gut.52.12.1703
   PubMed Web of Science ®Google Scholar
• Saito YA, Zimmerman JM, Harmsen WS, et al. Irritable bowel syndrome aggregates strongly in families: a family-based case control study. Neurogastroenterol Motil. 2008;20(7):790–797. doi: 10.1111/j.1365-2982.2007.01077.x
   PubMed Web of Science ®Google Scholar
• Bengtson MB, Ronning T, Vatn MH, et al. Irritable bowel syndrome in twins: genes and environment. Gut. 2006;55(12):1754–1759. doi: 10.1136/gut.2006.097287
   PubMed Web of Science ®Google Scholar
• Levy RL, Jones KR, Whitehead WE, et al. Irritable bowel syndrome in twins: heredity and social learning both contribute to etiology. Gastroenterology. 2001;121(4):799–804. doi: 10.1053/gast.2001.27995
   PubMed Web of Science ®Google Scholar
• Mohammed I, Cherkas LF, Riley SA, et al. Genetic influences in irritable bowel syndrome: a twin study. Am J Gastroenterol. 2005;100(6):1340–1344. doi: 10.1111/j.1572-0241.2005.41700.x
   PubMed Web of Science ®Google Scholar
• Morris-Yates A, Talley NJ, Boyce PM, et al. Evidence of a genetic contribution to functional bowel disorder. Am J Gastroenterol. 1998;93(8):1311–1317. doi: 10.1111/j.1572-0241.1998.440_j.x
   PubMed Web of Science ®Google Scholar
• Zucchelli M, Camilleri M, Andreasson AN, et al. Association of TNFSF15 polymorphism with irritable bowel syndrome. Gut. 2011;60(12):1671–1677. doi: 10.1136/gut.2011.241877
   PubMed Web of Science ®Google Scholar
• Camilleri M, Carlson P, McKinzie S, et al. Genetic susceptibility to inflammation and colonic transit in lower functional gastrointestinal disorders: preliminary analysis. Neurogastroenterol Motil. 2011;23(10):935–e398. doi: 10.1111/j.1365-2982.2011.01749.x
   PubMed Web of Science ®Google Scholar
• Swan C, Duroudier NP, Campbell E, et al. Identifying and testing candidate genetic polymorphisms in the irritable bowel syndrome (IBS): association with TNFSF15 and TNFα. Gut. 2013;62(7):985–994. doi: 10.1136/gutjnl-2011-301213
   PubMed Web of Science ®Google Scholar
• Wouters MM, Lambrechts D, Knapp M, et al. Genetic variants in CDC42 and NXPH1 as susceptibility factors for constipation and diarrhoea predominant irritable bowel syndrome. Gut. 2014;63(7):1103–1111. doi: 10.1136/gutjnl-2013-304570
   PubMed Web of Science ®Google Scholar
• Czogalla B, Schmitteckert A, Houghton LA, et al. A meta-analysis of immunogenetic case–control association studies in irritable bowel syndrome. Neurogastroenterol Motil. 2015;27(5):717–727. doi: 10.1111/nmo.12548
   PubMed Web of Science ®Google Scholar
• Ek WE, Reznichenko A, Ripke S, et al. Exploring the genetics of irritable bowel syndrome: a GWA study in the general population and replication in multinational case-control cohorts. Gut. 2015;64(11):1774–1782. doi: 10.1136/gutjnl-2014-307997
   PubMed Web of Science ®Google Scholar
• Bonfiglio F, Liu X, Smillie C, et al. GWAS of stool frequency provides insights into gastrointestinal motility and irritable bowel syndrome. Cell Genom. 2021 Dec 8;1(3):None. doi: 10.1016/j.xgen.2021.100069
   PubMedGoogle Scholar
• Drokhlyansky E, Smillie CS, Van Wittenberghe N, et al. The human and mouse enteric nervous system at single-cell resolution. Cell. 2020;182(6):1606–22.e23. doi: 10.1016/j.cell.2020.08.003
   PubMed Web of Science ®Google Scholar
• Montaño JA, Calavia MG, García-Suárez O, et al. The expression of ENa(+)C and ASIC2 proteins in pacinian corpuscles is differently regulated by TrkB and its ligands BDNF and NT-4. Neurosci Lett. 2009;463(2):114–118. doi: 10.1016/j.neulet.2009.07.073
   PubMed Web of Science ®Google Scholar
• Grider JR, Piland BE, Gulick MA, et al. Brain-derived neurotrophic factor augments peristalsis by augmenting 5-HT and calcitonin gene-related peptide release. Gastroenterology. 2006;130(3):771–780. doi: 10.1053/j.gastro.2005.12.026
   PubMed Web of Science ®Google Scholar
• Chen F, Yu Y, Wang P, et al. Brain-derived neurotrophic factor accelerates gut motility in slow-transit constipation. Acta Physiol (Oxf). 2014;212(3):226–238. doi: 10.1111/apha.12374
   PubMed Web of Science ®Google Scholar
• Coulie B, Szarka LA, Camilleri M, et al. Recombinant human neurotrophic factors accelerate colonic transit and relieve constipation in humans. Gastroenterology. 2000;119(1):41–50. doi: 10.1053/gast.2000.8553
   PubMed Web of Science ®Google Scholar
• Cottrell GS, Roosterman D, Marvizon JC, et al. Localization of calcitonin receptor-like receptor and receptor activity modifying protein 1 in enteric neurons, dorsal root ganglia, and the spinal cord of the rat. J Comp Neurol. 2005;490(3):239–255. doi: 10.1002/cne.20669
   PubMed Web of Science ®Google Scholar
• Cottrell GS, Alemi F, Kirkland JG, et al. Localization of calcitonin receptor-like receptor (CLR) and receptor activity-modifying protein 1 (RAMP1) in human gastrointestinal tract. Peptides. 2012;35(2):202–211. doi: 10.1016/j.peptides.2012.03.020
   PubMed Web of Science ®Google Scholar
• Sternini C. Enteric and visceral afferent CGRP neurons. Targets of innervation and differential expression patterns. Ann N Y Acad Sci. 1992;657(1):170–186. doi: 10.1111/j.1749-6632.1992.tb22766.x
   PubMedGoogle Scholar
• Esfandyari T, Macnaughton WK, Quirion R, et al. A novel receptor for calcitonin gene-related peptide (CGRP) mediates secretion in the rat colon: implications for secretory function in colitis. FASEB J Off Publ Fed Am Soc Exp Biol. 2000;14(10):1439–1446. doi: 10.1096/fj.14.10.1439
   PubMed Web of Science ®Google Scholar
• Cox HM, Ferrar JA, Cuthbert AW. Effects of α- and β-calcitonin gene-related peptides upon ion transport in rat descending colon. Br J Pharmacol. 1989;97(4):996–998. doi: 10.1111/j.1476-5381.1989.tb12553.x
   PubMed Web of Science ®Google Scholar
• Tanaka Y, Kanazawa M, Kano M, et al. Relationship between sympathoadrenal and pituitary-adrenal response during colorectal distention in the presence of corticotropin-releasing hormone in patients with irritable bowel syndrome and healthy controls. PLOS ONE. 2018;13(7):e0199698. doi: 10.1371/journal.pone.0199698
   PubMed Web of Science ®Google Scholar
• Camilleri M, Zhernakova A, Bozzarelli I, et al. Genetics of irritable bowel syndrome: shifting gear via biobank-scale studies. Nat Rev Gastroenterol Hepatol. 2022;19(11):689–702. doi: 10.1038/s41575-022-00662-2
   PubMed Web of Science ®Google Scholar
• Dema A, Faust D, Lazarow K, et al. Cyclin-dependent kinase 18 controls trafficking of aquaporin-2 and its abundance through ubiquitin ligase STUB1, which functions as an AKAP. Cells. 2020;9(3):673. doi: 10.3390/cells9030673
   PubMed Web of Science ®Google Scholar
• De Oliveira Pepino R, Coelho F, Aparecida Buzanello Janku T, et al. Overview of PCTK3/CDK18: a cyclin-dependent kinase involved in specific functions in post-mitotic cells. Curr Med Chem. 2021;28(33):6846–6865. doi: 10.2174/0929867328666210329122147
   PubMed Web of Science ®Google Scholar
• Jin S, Xu Y, Zang H, et al. Expression of genes related to lipid transport in meat-type ducks divergent for low or high residual feed intake. Asian-Australas J Anim Sci. 2020;33(3):416–423. doi: 10.5713/ajas.19.0284
   PubMed Web of Science ®Google Scholar
• Keck S, Galati-Fournier V, Kym U, et al. Lack of mucosal cholinergic innervation is associated with increased risk of enterocolitis in Hirschsprung’s disease. Cell Mol Gastroenterol Hepatol. 2021;12(2):507–545. doi: 10.1016/j.jcmgh.2021.03.004
   PubMed Web of Science ®Google Scholar
• Schafmayer C, Harrison JW, Buch S, et al. Genome-wide association analysis of diverticular disease points towards neuromuscular, connective tissue and epithelial pathomechanisms. Gut. 2019;68(5):854–865. doi: 10.1136/gutjnl-2018-317619
   PubMed Web of Science ®Google Scholar
• Linsalata M, Prospero L, Riezzo G, et al. Somatization is associated with altered serum levels of vitamin D, serotonin, and brain-derived neurotrophic factor in patients with predominant diarrhea irritable bowel syndrome. Neutogastroenterol Motil. 2023;35(3):e14512. doi: 10.1111/nmo.14512
   PubMed Web of Science ®Google Scholar
• Chang W-Y, Yang Y-T, She M-P, et al. 5-HT7 receptor-dependent intestinal neurite outgrowth contributes to visceral hypersensitivity in irritable bowel syndrome. Lab Invest. 2022;102(9):1023–1037. doi: 10.1038/s41374-022-00800-z
   PubMed Web of Science ®Google Scholar
• Vodicka M, Ergang P, Hrncir T, et al. Microbiota affects the expression of genes involved in HPA axis regulation and local metabolism of glucocorticoids in chronic psychosocial stress. Brain Behav Immun. 2018;73:615–624. doi: 10.1016/j.bbi.2018.07.007
   PubMed Web of Science ®Google Scholar
• Fukudo S. Role of corticotropin-releasing hormone in irritable bowel syndrome and intestinal inflammation. J Gastroenterol. 2007;42(Suppl 17):48–51. doi: 10.1007/s00535-006-1942-7
   PubMedGoogle Scholar
• Kasubuchi M, Hasegawa S, Hiramatsu T, et al. Dietary gut microbial metabolites, short-chain fatty acids, and host metabolic regulation. Nutrients. 2015;7(4):2839–2849. doi: 10.3390/nu7042839
   PubMed Web of Science ®Google Scholar
• Eijsbouts C, Zheng T, Kennedy NA, et al. Genome-wide analysis of 53,400 people with irritable bowel syndrome highlights shared genetic pathways with mood and anxiety disorders. Nat Genet. 2021;53(11):1543–1552. doi: 10.1038/s41588-021-00950-8
   PubMed Web of Science ®Google Scholar
• Wu Y, Murray GK, Byrne EM, et al. GWAS of peptic ulcer disease implicates Helicobacter pylori infection, other gastrointestinal disorders and depression. Nat Commun. 2021;12(1):1146. doi: 10.1038/s41467-021-21280-7
   PubMed Web of Science ®Google Scholar
• Gong W, Guo P, Li Y, et al. Role of the gut-brain axis in the shared genetic etiology between gastrointestinal tract diseases and psychiatric disorders: a genome-wide pleiotropic analysis. JAMA Psychiatry. 2023;80(4):360–370. doi: 10.1001/jamapsychiatry.2022.4974
   PubMed Web of Science ®Google Scholar
• Nagel M, Watanabe K, Stringer S, et al. Item-level analyses reveal genetic heterogeneity in neuroticism. Nat Commun. 2018;9(1):905. doi: 10.1038/s41467-018-03242-8
   PubMedGoogle Scholar
• Bock HH, Herz J. Reelin activates SRC family tyrosine kinases in neurons. Curr Biol. 2003;13(1):18–26. doi: 10.1016/S0960-9822(02)01403-3
   PubMed Web of Science ®Google Scholar
• Kim H-J, Hur SW, Park JB, et al. Histone demethylase PHF2 activates CREB and promotes memory consolidation. EMBO Rep. 2019;20(9):e45907. doi: 10.15252/embr.201845907
   PubMed Web of Science ®Google Scholar
• Detera-Wadleigh SD, Liu C-Y, Maheshwari M, et al. Sequence variation in DOCK9 and heterogeneity in bipolar disorder. Psychiatr Genet. 2007;17(5):274–286. doi: 10.1097/YPG.0b013e328133f352
   PubMed Web of Science ®Google Scholar
• Soufi-Afshar I, Moghadamnia A, Bijani A, et al. Comparison of pyridostigmine and bisacodyl in the treatment of refractory chronic constipation. Caspian J Intern Med. 2016 Winter;7(1):19–24.
   PubMedGoogle Scholar
• Manini ML, Camilleri M, Grothe R, et al. Application of pyridostigmine in pediatric gastrointestinal motility disorders: a case series. Paediatr Drugs. 2018;20(2):173–180. doi: 10.1007/s40272-017-0277-6
   PubMed Web of Science ®Google Scholar
• Dinan TG, Clarke G, Quigley EM, et al. Enhanced cholinergic-mediated increase in the pro-inflammatory cytokine IL-6 in irritable bowel syndrome: role of muscarinic receptors. Am J Gastroenterol. 2008;103(10):2570–2576. doi: 10.1111/j.1572-0241.2008.01871.x
   PubMed Web of Science ®Google Scholar
• Parkman HP, Rao SS, Reynolds JC, et al. Functional constipation study investigators. Neurotrophin-3 improves functional constipation. Am J Gastroenterol. 2003;98(6):1338–1347. doi: 10.1111/j.1572-0241.2003.t01-1-07477.x
   PubMed Web of Science ®Google Scholar
• Mahurkar-Joshi S, Chang L. Epigenetic mechanisms in irritable bowel syndrome. Front Psychiatry. 2020;11:805. doi: 10.3389/fpsyt.2020.00805
   PubMed Web of Science ®Google Scholar
• Bradford K, Shih W, Videlock EJ, et al. Association between early adverse life events and irritable bowel syndrome. Clin Gastroenterol Hepatol. 2012;10(4):385–390.e3. doi: 10.1016/j.cgh.2011.12.018
   PubMed Web of Science ®Google Scholar
• Park SH, Videlock EJ, Shih W, et al. Adverse childhood experiences are associated with irritable bowel syndrome and gastrointestinal symptom severity. Neurogastroenterol Motil. 2016;28(8):1252–1260. doi: 10.1111/nmo.12826
   PubMed Web of Science ®Google Scholar
• Parker CH, Naliboff BD, Shih W, et al. Negative events during adulthood are associated with symptom severity and altered stress response in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol. 2019;17(11):2245–2252. doi: 10.1016/j.cgh.2018.12.029
   PubMed Web of Science ®Google Scholar
• Meaney MJ, Szyf M. Environmental programming of stress responses through DNA methylation: life at the interface between a dynamic environment and a fixed genome. Dialogues Clin Neurosci. 2005;7(2):103–123. doi: 10.31887/DCNS.2005.7.2/mmeaney
   PubMedGoogle Scholar
• Dothel G, Barbaro MR, Di Vito A, et al. New insights into irritable bowel syndrome pathophysiological mechanisms: contribution of epigenetics. J Gastroenterol. 2023;58(7):605–621. doi: 10.1007/s00535-023-01997-6
   PubMed Web of Science ®Google Scholar
• Paul B, Barnes S, Demark-Wahnefried W, et al. Influences of diet and the gut microbiome on epigenetic modulation in cancer and other diseases. Clin Epigenet. 2015;7(1):112. doi: 10.1186/s13148-015-0144-7
   PubMedGoogle Scholar
• Liu S, da Cunha AP, Rezende RMM, et al. The host shapes the gut microbiota via fecal microRNA. Cell Host Microbe. 2016;19(1):32–43. doi: 10.1016/j.chom.2015.12.005
   PubMed Web of Science ®Google Scholar
• Smith DA, Sadler MC, Altman RB. Promises and challenges in pharmacoepigenetics. Camb Prism Precis Med. 2023 Feb 9;1:e18. doi: 10.1017/pcm.2023.6
   PubMedGoogle Scholar
• Kacevska M, Ivanov M, Ingelman-Sundberg M. Perspectives on epigenetics and its relevance to adverse drug reactions. Clin Pharmacol Ther. 2011;89(6):902–907. doi: 10.1038/clpt.2011.21
   PubMed Web of Science ®Google Scholar
• Banerjee M. Pharmacoepigenomics: a key determinant in resolving epigenomic parameters in pathogenesis and treatment response in complex diseases. Pharmacogenomics. 2022;23(2):81–84. doi: 10.2217/pgs-2021-0140
   PubMed Web of Science ®Google Scholar
• Swathy B, Saradalekshmi KR, Nair IV, et al. Pharmacoepigenomic responses of antipsychotic drugs on pharmacogenes are likely to be modulated by miRnas. Epigenomics. 2017;9:811–821. doi: 10.2217/epi-2016-0181
   PubMed Web of Science ®Google Scholar
• Jin J, Zhong XB. Epigenetic mechanisms contribute to intraindividual variations of drug metabolism mediated by cytochrome P450 enzymes. Drug Metab Dispos. 2023;51(6):672–684. doi: 10.1124/dmd.122.001007
   PubMed Web of Science ®Google Scholar
• Powell TR, Smith RG, Hackinger S, et al. DNA methylation in interleukin-11 predicts clinical response to antidepressants in GENDEP. Transl Psychiatry. 2013;3(9):e300. doi: 10.1038/tp.2013.73
   PubMedGoogle Scholar
• Radosavljevic M, Svob Strac D, Jancic J, et al. The role of pharmacogenetics in personalizing the antidepressant and anxiolytic therapy. Genes (Basel). 2023;14(5):1095. doi: 10.3390/genes14051095
   PubMed Web of Science ®Google Scholar
• Hong S, Zheng G, Wiley JW. Epigenetic regulation of genes that modulate chronic stress-induced visceral pain in the peripheral nervous system. Gastroenterology. 2015;148(1):148–157.e7. doi: 10.1053/j.gastro.2014.09.032
   PubMed Web of Science ®Google Scholar
• Wiley JW, Zong Y, Zheng G, et al. Histone H3K9 methylation regulates chronic stress and IL-6–induced colon epithelial permeability and visceral pain. Neurogastroenterol Motil. 2020;32(12):e13941. doi: 10.1111/nmo.13941
   PubMed Web of Science ®Google Scholar
• Zheng L, Kelly CJ, Battista KD, et al. Microbial-derived butyrate promotes epithelial barrier function through IL-10 receptor-dependent repression of claudin-2. J Immunol. 2017;199:2976–2984. doi: 10.4049/jimmunol.1700105
   PubMed Web of Science ®Google Scholar
• Zhou Q, Yang L, Larson S, et al. Decreased miR-199 augments visceral pain in patients with IBS through translational upregulation of TRPV1. Gut. 2016;65(5):797–805. doi: 10.1136/gutjnl-2013-306464
   PubMed Web of Science ®Google Scholar
• Martı´nez C, Rodino˜-Janeiro BK, Lobo B, et al. miR-16 and miR-125b are involved in barrier function dysregulation through the modulation of claudin-2 and cingulin expression in the jejunum in IBS with diarrhoea. Gut. 2017;66(9):1537.1–1538. doi: 10.1136/gutjnl-2016-311477
   Web of Science ®Google Scholar
• Venkova K, Johnson AC, Myers B, et al. Exposure of the amygdala to elevated levels of corticosterone alters colonic motility in response to acute psychological stress. Neuropharmacology. 2010;58(7):1161–1167. doi: 10.1016/j.neuropharm.2010.02.012
   PubMed Web of Science ®Google Scholar
• Greenwood-Van Meerveld B, Moloney RD, Johnson AC, et al. Mechanisms of stress-induced visceral pain: implications in irritable bowel syndrome. J Neuroendocrinol. 2016 Aug;28(8). doi: 10.1111/jne.12361
   PubMed Web of Science ®Google Scholar
• Taché Y, Million M. Role of corticotropin-releasing factor signaling in stress-related alterations of colonic motility and Hyperalgesia. J Neurogastroenterol Motil. 2015;21(1):008–024. doi: 10.5056/jnm14162
   PubMed Web of Science ®Google Scholar
• Larauche M, Moussaoui N, Biraud M, et al. Brain corticotropin-releasing factor signaling: involvement in acute stress induced visceral analgesia in male rats. Neurogastroenterol Motil. 2019;31(2):e13489. doi: 10.1111/nmo.13489
   PubMed Web of Science ®Google Scholar
• Lennon EM, Maharshak N, Elloumi H, et al. Early life stress triggers persistent colonic barrier dysfunction and exacerbates colitis in adult IL-10−/− mice. Inflammation Bowel Dis. 2013;19(4):712–719. doi: 10.1097/MIB.0b013e3182802a4e
   PubMed Web of Science ®Google Scholar
• Santos J, Benjamin M, Yang PC, et al. Chronic stress impairs rat growth and jejunal epithelial barrier function: role of mast cells. Am J Physiol Gastrointest Liver Physiol. 2000;278(6):G847–54. doi: 10.1152/ajpgi.2000.278.6.G847
   PubMed Web of Science ®Google Scholar
• Castagliuolo I, Lamont JT, Qiu B, et al. Acute stress causes mucin release from rat colon: role of corticotropin releasing factor and mast cells. Am J Physiol. 1996;271(5):G884–92. doi: 10.1152/ajpgi.1996.271.5.G884
   PubMedGoogle Scholar
• Moloney RD, Stilling RM, Dinan TG, et al. Early-life stress-induced visceral hypersensitivity and anxiety behavior is reversed by histone deacetylase inhibition. Neurogastroenterol Motil. 2015;27(12):1831–1836. doi: 10.1111/nmo.12675
   PubMed Web of Science ®Google Scholar
• Moloney RD, Johnson AC, O’Mahony SM, et al. Stress and the microbiota–gut–brain axis in visceral pain: relevance to irritable bowel syndrome. CNS Neurosci Ther. 2016;22(2):102–117. doi: 10.1111/cns.12490
   PubMed Web of Science ®Google Scholar
• Aguirre JE, Winston JH, Sarna SK. Neonatal immune challenge followed by adult immune challenge induces epigenetic-susceptibility to aggravated visceral hypersensitivity. Neurogastroenterol Motil. 2017;29(9):125. doi: 10.1111/nmo.13081
   Web of Science ®Google Scholar
• Li Q, Winston JH, Sarna SK. Developmental origins of colon smooth muscle dysfunction in IBS-like rats. Am J Physiol Gastrointest Liver Physiol. 2013;305(7):G503–12. doi: 10.1152/ajpgi.00160.2013
   PubMed Web of Science ®Google Scholar
• Mahurkar S, Polytarchou C, Iliopoulos D, et al. Genome-wide DNA methylation profiling of peripheral blood mononuclear cells in irritable bowel syndrome. Neurogastroenterol Motil. 2016;28(3):410–422. doi: 10.1111/nmo.12741
   PubMed Web of Science ®Google Scholar
• Welgan P, Meshkinpour H, Beeler M. Effect of anger on colon motor and myoelectric activity in irritable bowel syndrome. Gastroenterology. 1988;94(5):1150–1156. doi: 10.1016/0016-5085(88)90006-6
   PubMed Web of Science ®Google Scholar
• Posserud I, Agerforz P, Ekman R, et al. Altered visceral perceptual and neuroendocrine response in patients with irritable bowel syndrome during mental stress. Gut. 2004;53(8):1102–1108. doi: 10.1136/gut.2003.017962
   PubMed Web of Science ®Google Scholar
• Dickhaus B, Mayer EA, Firooz N, et al. Irritable bowel syndrome patients show enhanced modulation of visceral perception by auditory stress. Am J Gastroenterol. 2003;98(1):135–143. doi: 10.1111/j.1572-0241.2003.07156.x
   PubMed Web of Science ®Google Scholar
• Videlock EJ, Shih W, Adeyemo M, et al. The effect of sex and irritable bowel syndrome on HPA axis response and peripheral glucocorticoid receptor expression. Psychoneuroendocrinology. 2016;69:67–76. doi: 10.1016/j.psyneuen.2016.03.016
   PubMed Web of Science ®Google Scholar
• Drossman DA, Tack J, Ford AC, et al. Neuromodulators for functional gastrointestinal disorders (disorders of Gut−Brain interaction): a Rome foundation working team report. Gastroenterology. 2018;154(4):1140–1171.e1. doi: 10.1053/j.gastro.2017.11.279
   PubMed Web of Science ®Google Scholar
• Blagec K, Swen JJ, Koopmann R, et al. Pharmacogenomics decision support in the U-PGx project: results and advice from clinical implementation across seven European countries. PLOS ONE. 2022;17(6):e0268534. doi: 10.1371/journal.pone.0268534
   PubMed Web of Science ®Google Scholar